Sectoral / ThematicVery High
Aditya Birla Sun Life Pharma and Healthcare Fund · Direct · Growth
NAV
₹40.4800
as of 29 Sept 2026
Expense Ratio
1.05%
Viewing Direct · Growth
Riskometer
Very High
Lumpsum returns (CAGR)
- 1Y
- +21.09%
- 3Y
- +20.96%
- 5Y
- +14.61%
- Since Inception
- +21.36%
SIP returns (XIRR)
- 1Y
- +25.44%
- 3Y
- +17.16%
- 5Y
- +19.41%
- Since Inception
- +19.61%
Performance Comparison
Sectoral allocation
as of 31 Aug 2026- Pharmaceuticals & Biotechnology73.27%
- Healthcare Services21.58%
- Insurance0.78%
- Chemicals & Petrochemicals0.77%
Each sector links to the mutual funds most exposed to it.
Thinking about Aditya Birla Sun Life Pharma and Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Compare All Sectoral / Thematic FundsView all Sectoral / Thematic funds
Fund Details
Fund HouseAditya Birla Sun Life Mutual Fund
CategorySectoral / Thematic
Launch Date10 Jul 2019
AMFI Code147409
Transaction facts
Min. Lumpsum₹1,000
Min. SIP₹10
Exit LoadExit Load: For redemption / switch-out of units on or before 90 days from the date of allotment: 0.5% of applicable NAV and after 90 days from the date of allotment: : Nil
Available transactions
PurchaseSIPRedeemSWPSwitchSTPDemat
Portfolio holdings
as of 31 Aug 2026
portfolio shared with Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Holding% NAV
- 1Torrent Pharmaceuticals Ltd.9.57%
- 2Sun Pharmaceutical Industries Ltd.9.19%
- 3Apollo Hospitals Enterprise Ltd.6.85%
- 4Cipla Ltd.5.16%
- 5Aurobindo Pharma Ltd.4.53%
- 6Ajanta Pharma Ltd.4.22%
- 7Sai Life Sciences Ltd.4.20%
- 8Mankind Pharma Ltd.3.41%
- 9Lupin Ltd.3.10%
- 10Abbott India Ltd.3.03%
Rows per page· 39 total
Page 1/4
Investment objective — in the AMC’s words
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
About This Fund
Aditya Birla Sun Life Pharma and Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Aditya Birla Sun Life Mutual Fund. The fund has been operational for over 7 years. The current expense ratio is 1.05%.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •SIP investors who can benefit from rupee cost averaging during market fluctuations